Background Among low-risk patients with severe, symptomatic aortic stenosis who are
eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve …

Background Despite the initial evidence supporting the utility of intravascular imaging to
guide percutaneous coronary intervention (PCI), adoption remains low. Recent new trial …

Background We performed a meta‐analysis of reconstructed time‐to‐event data from
randomized controlled trials (RCTs) and propensity‐score matched (PSM) studies …

(1) Background: The use of transcatheter aortic valve implantation (TAVI) for the treatment of
severe symptomatic aortic stenosis is expanding significantly. We aimed to perform a meta …

Abstract Background The balloon expandable Myval transcatheter heart valve (THV)
showed encouraging results regarding residual aortic regurgitation (AR) from multiple …

Summary of randomized controlled strategy trials comparing TAVI vs. SAVR. The y-axis
indicates all-cause mortality (%) at 1 year in patients undergoing TAVI or SAVR. Bubble size …

In microbiological research, traditional methods for bacterial screening and antibiotic
susceptibility testing are resource‐intensive. Microfluidics offers an efficient alternative with …

OBJECTIVES The concept of non-inferiority is widely adopted in randomized trials
comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve …

Background Stroke is a feared complication of transcatheter aortic valve replacement
(TAVR), which embolic protection devices (EPDs) may mitigate. This systematic review and …

Background Transcatheter aortic valve implantation (TAVI) is a well-established treatment
for high and intermediate-risk patients with severe aortic stenosis (AS). Recent studies have …